GEDI Cell Death Indicators Resolving Calcium Signal Specificity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for monitoring cell death, particularly neuronal cell death, lack efficient and accurate tools for detecting changes in intracellular calcium levels, which are critical for maintaining cellular homeostasis and viability.

Innovation Solution

The development of genetically encoded death indicators (GEDI) that utilize modified calcium binding motifs and fluorescent markers to detect changes in intracellular calcium levels, allowing for the differentiation between live and dead cells based on calcium homeostasis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional calcium indicators are used to monitor cell death, then calcium levels can be detected, but the indicators cannot reliably distinguish between physiological calcium fluctuations and pathological cell death

Engineering Contradiction:
Improvecell death detection accuracyVSAvoidsignal specificity
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The invention divides the detection function into two separate fluorescent proteins: GCaMP6f for detecting calcium levels and mRuby2 as a stable reference marker. This segmentation allows the system to distinguish between transient calcium fluctuations and actual cell death by comparing the dynamic calcium signal against the stable reference signal, thereby improving measurement precision while maintaining reliability.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention utilizes two fluorescent proteins with distinct emission spectra (green GCaMP6f and red mRuby2) to encode different information. The green channel reports physiological calcium levels that fluctuate during normal cell function, while the red channel provides a stable reference. This color-based encoding system enables reliable differentiation between physiological and pathological states through spectral discrimination.

Inventive Principle:
Principle #32Color changes

2Reliability

If standard fluorescent proteins are used for cell viability monitoring, then general fluorescence signal can be obtained, but they cannot provide acute and robust signals specifically indicating cell death

Engineering Contradiction:
Improvecell death indication accuracyVSAvoidsignal response speed and robustness
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The GCaMP6f component serves dual functions: it monitors physiological calcium dynamics during normal cell operation and simultaneously serves as a death indicator when its signal diverges from the mRuby2 reference signal. This multi-functionality allows a single protein to provide both baseline physiological information and pathological detection, enhancing both reliability and productivity without requiring separate indicator systems.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The system employs a ratiometric feedback mechanism where the fluorescence intensity ratio between GCaMP6f (green) and mRuby2 (red) is continuously monitored. Under normal conditions, calcium-induced GCaMP6f fluctuations are detected against the stable mRuby2 background. Upon cell death, the feedback mechanism detects sustained signal divergence, providing an acute and robust death indication that overcomes the limitations of standard single-channel fluorescent proteins.

Inventive Principle:
Principle #23Feedback

3Device complexity

If single fluorescent marker systems are used, then the system is simple, but it cannot differentiate between calcium transients and cell death events

Engineering Contradiction:
Improveindicator system structureVSAvoidcell state differentiation capability
Core Design Contradiction:
Device complexityVSMeasurement precision

Solution Approach 1:

The invention transitions from a single-dimensional fluorescence measurement to a two-dimensional ratiometric measurement system by incorporating two fluorescent proteins with different emission wavelengths. This dimensional expansion allows the system to simultaneously capture calcium dynamics (green channel) and maintain a stable reference (red channel), enabling precise differentiation between physiological and pathological states without prohibitively increasing system complexity.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Solution Approach 2:

The system exploits the dynamic response characteristics of GCaMP6f to calcium binding versus the stable expression of mRuby2. During physiological conditions, GCaMP6f dynamically fluctuates with calcium transients while mRuby2 remains stable. Upon cell death, this dynamic relationship breaks down, providing a measurable deviation that enables accurate cell state differentiation while maintaining relatively simple system architecture.

Inventive Principle:
Principle #15Dynamics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

GEDI effectively monitors cell death by providing a robust and acute signal that distinguishes between live and dead cells, even in the context of neurodegenerative diseases, and can be used in both in vitro and in vivo applications.

Implementation Method 1

GCaMP6f is a genetically encoded calcium indicator (GECI) that emits green light when bound to calcium ions

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Implementation Method 2

The isolated nucleic acid sequence encodes a modified calcium binding motif that exhibits increased affinity for calcium ions

Methodology Applied
Scientific EffectCalcium binding:

Implementation Method 3

The isolated nucleic acid sequence encodes a self-cleaving P2A peptide sequence that mediates ribosomal skipping during translation

Methodology Applied
Scientific EffectRibosomal skipping:

Data Source

PatentEP3529622B1Genetically encoded cell death indicators and methods of use
Publication Date: 2025.03.12 THE J DAVID GLADSTONE INSTITUTES
  • EP3529622B1 patent drawingFigure 1A~1B
  • EP3529622B1 patent drawingFigure 1C
  • EP3529622B1 patent drawingFigure 2A~2D

AI summary

Genetically encoded death indicator (GEDI) polypeptides and nucleic acid molecules encoding such polypeptides are provided. In addition, methods of using such nucleic acids and polypeptides to monitor cell death events in vitro and in vivo, particularly in neuronal cell death, are also provided.